A new analysis reveals that Finland, a Nordic country, has the highest global rate of childhood type 1 diabetes. The condition has seen a nearly 40% surge in cases among children worldwide since 1990. Type 1 diabetes, a chronic autoimmune disorder requiring daily insulin injections, cannot be prevented through diet or exercise, distinguishing it from many cases of type 2 diabetes.
Global Overview
In 2021, over 222,000 children under 15 years old were living with type 1 diabetes, according to a study published in JAMA Pediatrics. However, the mortality rate has decreased significantly, with 4,280 deaths reported that year. The decline is attributed to advancements in care and management.
“Despite these improvements, addressing childhood diabetes prevention remains complex,” stated Dr. Xiaodong Sun, a clinical researcher at the Affiliated Hospital of Shandong Second Medical University in China.
European Disparities
Childhood type 1 diabetes rates vary significantly across Europe. Finland leads globally with an incidence rate of 70 per 100,000 children under 15, followed by Malta, Ireland, Italy, Norway, and Spain, each exceeding 30 cases per 100,000. In contrast, Central and Eastern European countries, including Romania, Belarus, and Moldova, report rates of 10 or fewer.
Potential Causes and Contributing Factors
Researchers suggest that access to healthcare may play a role, as high-income countries often facilitate earlier diagnosis and better management. Environmental factors are also under scrutiny. Northern countries like Finland receive less ultraviolet radiation from sunlight, which may slow immune responses and offer some protection against diabetes.
Global Trends and Challenges
Between 2019 and 2021, the global incidence of childhood diabetes slightly increased from 10.9 to 11.1 per 100,000 children. Eastern Europe saw a more pronounced rise than other regions. Beyond Europe, South Asia, particularly India, bears the highest number of cases, while eastern sub-Saharan Africa has the highest mortality rates.
In low- and middle-income countries, the burden remains significant, underscoring the need for early interventions such as genetic risk monitoring and innovative immunotherapy treatments. “These measures are vital for improving outcomes and reducing the global impact of childhood diabetes,” Dr. Sun emphasized.
The steady rise in childhood type 1 diabetes worldwide highlights the urgent need for more comprehensive research, preventive measures, and equitable access to care. Countries with high incidence rates, like Finland, provide valuable case studies to explore the interplay of genetics, environment, and healthcare systems in managing this chronic condition.
Source: Euronews
Comments